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Endobronchial Stent Insertion to Manage Hemoptysis caused by 
Lung Cancer
Hemoptysis in patients with lung cancer is not uncommon and sometimes have dangerous 
consequences. Hemoptysis has been managed with various treatment options other than 
surgery and medicine, such as endobronchial tamponade, transcatheter arterial 
embolization and radiation therapy. However, these methods can sometimes be used only 
temporarily or are not suitable for a patient’s condition. We present a case in which 
uncontrollable hemoptysis caused by central lung cancer was successfully treated by 
inserting a covered self-expanding bronchial stent. The patient could be extubated and was 
able to undergo further palliative therapy. No recurrent episodes of hemoptysis occurred 
for the following three months. As our case, airway stenting is a considerable option for the 
tamponade of a bleeding lesion that cannot be successfully managed with other treatment 
methods and could be used to preserve airway patency in a select group of patients.
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CASE REPORT
Medical Imaging
INTRODUCTION
Hemoptysis is not uncommon manifestation of pulmonary dis-
ease including lung cancer (1, 2). Hemoptysis can be fatal and 
therefore early detection and proper management is critical. 
Management options for hemoptysis include pharmacological 
or bronchoscopic therapy, transcatheter embolization and sur-
gical resection. Endobronchial tamponade is another treatment 
option for hemoptysis, especially in cases involving central air-
way lesions. Endobronchial tamponade is used not only to con-
trol bleeding but also to protect the contralateral lung. Endobron-
chial tamponade is commonly achieved using a double-lumen 
endobronchial tube or by the placement of an endobronchial 
balloon. These methods are effective, but require prolonged 
mechanical ventilation (3).
  We present a case in which bleeding caused by cancer in the 
left central lung was successfully managed by tamponade with 
a polytetrafluoroethylene (PTFE)-covered self-expanding bron-
chial stent that allowed the patient to be extubated and to un-
dergo further palliative therapy.
CASE REPORT
A 49-yr-old male visited our hospital because of dysphasia, hoa–
rseness and a 10 kg weight loss experienced over the previous 
three months. Approximately five months prior to this visit, the 
patient was diagnosed with a central lung mass in the left hilar 
area based on a chest radiograph obtained during a health check. 
However, the patient refused further evaluation at the time. We 
performed computed tomography (CT) imaging, which revealed 
a huge central lung mass obstructing the left main bronchus and 
the proximal portion of the left upper and lower lobar bronchi. 
This mass invaded the carina, adjacent esophagus and left main 
pulmonary artery surrounding the descending thoracic aorta. 
A bronchoscopic biopsy was performed and the mass was final-
ly confirmed as non-small cell lung cancer, specifically a squa-
mous cell carcinoma. After a 12 cm covered esophageal stent 
was inserted to relieve dysphagia, chemotherapy was started. 
About one month later, the patient revisited the emergency de-
partment with sudden aggravation of dyspnea and coughing. 
Respiration rates were initially 36/min and increased to 44/min 
for one hour after hospitalization. The patient was intubated for 
mechanical ventilator support and was managed in the inten-
sive care unit. Blood-tinged sputum developed during the first 
day of admission. Three days after admission, a chest radiogra-
phy showed the left lung had totally collapsed and bloody secre-
tions were aggravated with no evidence of coagulopathy. The 
hemoglobin level had dropped from 10.7 g/dL to 8.8 g/dL dur-
ing the course of one day. At this time, a bronchoscopic exami-
nation demonstrated the presence of an endoluminal protrud-
ing mass with extrinsic compression from the distal trachea to 
the left main bronchus. The orifice of the left main bronchus was 
completely obstructed by the mass and was coated by bloody 
and fibrinous clots. There was diffuse bleeding from the muco-
sal surface of the mass without a localized focus. Epinephrine 
was sprayed on the area to control the bleeding. However, this Chung IH, et al.  •  Endobronchial Stent Insertion to Manage Hemoptysis
DOI: 10.3346/jkms.2010.25.8.1253 1254   http://jkms.org
was only temporarily effective and bleeding continued intermit-
tently. From the eighth day after admission, blood was aspirat-
ed through endotracheal tube continuously. Bronchial artery 
embolization could not be considered as an option to control 
the bleeding, because it was not active arterial bleeding  and 
there was no prominent contrast enhancement of the mass as 
seen on a CT scan. Surgical resection also could not be consid-
ered because of the advanced stage of the cancer. On the tenth 
day after admission, a bronchial stent was inserted to achieve a 
tamponade effect to stop the bleeding and to maintain luminal 
patency of the left main bronchus. A hydrophilic guidewire (Ra-
diofocus: Terumo, Tokyo, Japan) was inserted under broncho-
scopic guidance and an angiographic catheter (Angled Taper; 
Terumo, Tokyo, Japan) was then advanced into the lower lobar 
bronchus. A small amount of non-ionic contrast material was 
injected into the airway to identify the bronchial tree, as we were 
unable to discriminate the airway on a fluoroscopic image due 
to the total collapse of the left lung. A stiff guidewire (Amplatz 
Super Stiff; Boston Scientific, Watertown, MA, USA) was inserted 
into the left lower lobar bronchus and a 12 mm-6 cm self-ex-
panding polytetrafluoroethylene (PTFE)-covered nitinol stent 
(Taewoong Medical, Seoul, Korea) was deployed in the left main 
bronchus under fluoroscopic guidance (Fig. 1). Blood in the en-
dotracheal tube decreased markedly and dyspnea was relieved 
soon after bronchial stent placement. Two days after the stent 
placement, the patient was extubated and blood-tinged sputum 
had disappeared completely four days later (Fig. 2). Radiation 
therapy was started eleven days after stent placement. During 
radiation therapy, a total collapse of the left lung again devel-
oped. A mass in the proximal left main bronchus that was not 
covered by the stent was removed by bronchoscopy and left lung 
aeration improved. The patient expired three months after stent 
placement due to disease progression. During this period, there 
was no frank hemoptysis, except for several episodes of blood-
tinged sputum.
 
B A
Fig. 1. A bronchial stent was placed in the left main bronchus. (A) A fluoroscopic image shows the bronchial stent and a totally collapsed left lung. (B) Bronchoscopy performed 
just after the bronchial stent placement shows the proximal end of the stent, which was exactly positioned at the orifice of the left main bronchus.
Fig. 2. A multi-planar reformatted oblique coronal CT image obtained six days after 
the bronchial stent placement shows the bronchial stent in the left main bronchus 
with internal bubbly material, suggesting secretion and an aerated left lung.Chung IH, et al.  •  Endobronchial Stent Insertion to Manage Hemoptysis
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DISCUSSION
Common causes of hemoptysis are benign diseases; however, 
hemoptysis can also occur in patients with lung cancer with a 
rate as high as 27% (1, 2). Hemoptysis due to lung cancer is usu-
ally mild, resulting in blood-streaked sputum (4). In most cases, 
hemoptysis results from the erosion of small, friable mucosal 
vessels. Massive hemoptysis can sometimes occur due to malig-
nant invasion of central pulmonary vessels by tumors (4). He-
moptysis can be life threatening and the condition can delay the 
proper treatment of underlying disease. 
  Hemoptysis can be managed by localizing the bleeding source 
and by providing specific treatment. To protect the contralateral 
lung, patients may be selectively intubated or ventilated with a 
double-lumen endotracheal tube. There have been occasional 
reports of successful tamponade by the use of airway balloons 
deployed by bronchoscopy (3). However, these methods offer 
only temporary relief and prolonged mechanical ventilation is 
needed. Conventional radiation therapy also offers excellent 
palliation of hemoptysis in lung cancer in up to 80% of cases (5). 
However, patients must be physically able to undergo radiation 
therapy, and sometimes multisession treatments are necessary. 
Bronchial artery embolization has been accepted as an effec-
tive modality to temporize the bleeding. However, most reports 
of bronchial artery embolization are limited. with a few cases of 
lung cancer (6-8).
  To the best of our knowledge, there is one case report that has 
described airway stent placement to achieve tamponade and 
isolation of the bleeding source from lung cancer (9). However, 
bleeding was successfully controlled after the second stent place-
ment that isolated the bleeding mass lesion in the previous case. 
We achieved successful tamponade with the first stent in the 
main bronchus, as the lung cancer, which was the source of bleed-
ing, was centrally located. We also achieved patency of the ste-
notic main bronchus that had been invaded by the tumor. The 
second event of left lung collapse without hemoptysis occurred 
during radiation therapy. Considering the relative short period 
and the findings of bronchoscopy that was performed just after 
stent placement and showed the exact location of the proximal 
end of the stent at the orifice of the left main bronchus, we pre-
sumed that the finding was probably due to minimal distal mi-
gration of the stent rather than tumor overgrowth. We used a full 
covered stent; therefore, the possibility of migration was inevi-
table. Covered airway stents are effective to prevent tumor in-
growth or mucosal hyperplasia; however, stent migration, ac-
cumulation of secretion and sometimes membrane disruption 
can occur (10). Other significant complication such as an aorto-
bronchial fistula, especially in cases with non-covered stent, have 
also been rarely reported (11). A covered airway stent is designed 
as a retrievable stent and the sent can be removed when the pa-
tient responds to radiotherapy/chemotherapy and no longer 
requires the stent. However, stent removal is not commonly per-
formed for malignant strictures and removal time has not been 
established even for benign lesions (10, 12-14). The effectiveness 
of stent placement according to the location or tumor type has 
also not been established. Therefore, a further study is needed.
  In conclusion, airway stenting is a considerable option for 
the tamponade of a bleeding lesion in an airway that cannot be 
successfully managed with other treatment methods. Airway 
stenting also could be used to preserve airway patency in a se-
lect group of patients.
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